which glp-1 is best for cardiovascular benefit benefits of glucagon-like peptide-1 receptor agonists Cardiovascular benefits of GLP-1 meds
Description
Selection of antiobesity medications based on phenotypes enhances weight loss: a pragmatic trial in an obesity clinic
They may influence brain pathways involving appetite and mood regulation, including serotonin signaling
They also reported a 56.4% decrease in feelings of hunger
The law (Medicare Modernization Act of 2003) explicitly excludes drugs when used for weight loss, weight gain, or anorexia. (ASPE) Some proposed changes (including reinterpreting the exclusion for obesity) were considered , but in April 2025 those were not finalized
Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
Zhou B, Yuan Y, Shi L, Hu S, Wang D, Yang Y
